Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14733783

Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups. Discussions

Author
BLASETTO, James W1 ; STEIN, Evan A2 3 ; BROWN, W. Virgil4 ; CHITRA, Rohini1 ; RAZA, Ali1 ; MCKENNEY, James M (Commentator)
[1] AstraZeneca LP, Wilminglon, Delaware, United States
[2] Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio, United States
[3] Medical Research laboratories International, Highland Heights, Kentucky, United States
[4] Emory University School of Medicine, Atlanta, Georgia, United States
Conference title
A symposium: Rosuvastatin-An Efficacy Assessment Based on Pooled Trial Data
Conference name
A Symposium: Rosuvastatin-An Efficacy Assessment Based on Pooled Trial Data (Atlanta, Georgia 2002-03-15)
Author (monograph)
STEIN, Evan A (Editor)1 2
[1] Medical Research Laboratories International, 2 Tesseneer Drive, Highland Heights, Kentucky 41076, United States
[2] Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio, United States
Source

The American journal of cardiology. 2003, Vol 91, Num 5A, pp 3C-10C ; ref : 25 ref

CODEN
AJCDAG
ISSN
0002-9149
Scientific domain
Cardiology, blood circulation, phlebology
Publisher
Elsevier, New York, NY
Publication country
United States
Document type
Conference Paper
Language
English
Keyword (fr)
Atorvastatine Chimiothérapie Dose Etude comparative Exploration Homme Hypercholestérolémie Lipide Pravastatine Rosuvastatine Simvastatine Statine dérivé Traitement Dyslipémie Enzyme Hydroxymethylglutaryl-CoA reductase Hyperlipoprotéinémie Hypolipémiant Inhibiteur enzyme Métabolisme pathologie Oxidoreductases
Keyword (en)
Atorvastatin Chemotherapy Dose Comparative study Exploration Human Hypercholesterolemia Lipids Pravastatin Rosuvastatin Simvastatin Statin derivative Treatment Dyslipemia Enzyme Hydroxymethylglutaryl-CoA reductase Hyperlipoproteinemia Antilipemic agent Enzyme inhibitor Metabolic diseases Oxidoreductases
Keyword (es)
Atorvastatina Quimioterapia Dosis Estudio comparativo Exploración Hombre Hipercolesterolemia Lípido Pravastatina Rosuvastatina Simvastatina Statina derivado Tratamiento Dislipemia Enzima Hydroxymethylglutaryl-CoA reductase Hiperlipoproteinemia Hipolipemiante Inhibidor enzima Metabolismo patología Oxidoreductases
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02N General and cellular metabolism. Vitamins

Discipline
Pharmacological treatments
Origin
Inist-CNRS
Database
PASCAL
INIST identifier
14733783

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Searching the Web